A Phase IIa Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/orMycobacterium tuberculosis–infected Adults
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Phase IIa Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/orMycobacterium tuberculosis–infected Adults
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Volume 185, Issue 7, Pages 769-778
Publisher
American Thoracic Society
Online
2012-01-27
DOI
10.1164/rccm.201108-1548oc
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multifunctional, High-Level Cytokine-Producing Th1 Cells in the Lung, but Not Spleen, Correlate with Protection against Mycobacterium tuberculosis Aerosol Challenge in Mice
- (2014) E. K. Forbes et al. JOURNAL OF IMMUNOLOGY
- Prospects for elimination of childhood tuberculosis: the role of new vaccines
- (2011) M. Hatherill ARCHIVES OF DISEASE IN CHILDHOOD
- HIV-1/Mycobacterium tuberculosisCoinfection Immunology: How Does HIV-1 Exacerbate Tuberculosis?
- (2011) Collin R. Diedrich et al. INFECTION AND IMMUNITY
- Functional Capacity of Mycobacterium tuberculosis-Specific T Cell Responses in Humans Is Associated with Mycobacterial Load
- (2011) C. L. Day et al. JOURNAL OF IMMUNOLOGY
- Dose-Finding Study of the Novel Tuberculosis Vaccine, MVA85A, in Healthy BCG-Vaccinated Infants
- (2011) Thomas J. Scriba et al. JOURNAL OF INFECTIOUS DISEASES
- A multistage tuberculosis vaccine that confers efficient protection before and after exposure
- (2011) Claus Aagaard et al. NATURE MEDICINE
- Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants
- (2011) M. O. C. Ota et al. Science Translational Medicine
- Prevention of tuberculosis in Bacille Calmette–Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine
- (2010) Charles F von Reyn et al. AIDS
- Specific T Cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis after Bacillus Calmette-Guérin Vaccination of Newborns
- (2010) Benjamin M. N. Kagina et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Preferential infection and depletion ofMycobacterium tuberculosis–specific CD4 T cells after HIV-1 infection
- (2010) Christof Geldmacher et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: A phase III study in Tanzania
- (2010) Timothy Lahey et al. VACCINE
- Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa
- (2009) Stephen D Lawn et al. AIDS
- Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, inMycobacterium tuberculosis–infected Individuals
- (2009) Clare R. Sander et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- HIV-1 Infection Impairs the Bronchoalveolar T-Cell Response to Mycobacteria
- (2009) Barbara Kalsdorf et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells
- (2009) Thomas J. Scriba et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Clinical Prognostic Value of RNA Viral Load and CD4 Cell Counts during Untreated HIV-1 Infection—A Quantitative Review
- (2009) Eline L. Korenromp et al. PLoS One
- Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
- (2009) Kathryn T. Whelan et al. PLoS One
- Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
- (2009) L. J. Abu-Raddad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Healthy Adults in South Africa
- (2008) Tony Hawkridge et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa
- (2008) Roger H. Brookes et al. PLoS One
- Immunological Outcomes of New Tuberculosis Vaccine Trials: WHO Panel Recommendations
- (2008) Willem A Hanekom et al. PLOS MEDICINE
- Eliminating human tuberculosis in the twenty-first century
- (2007) C. Dye et al. Journal of the Royal Society Interface
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now